nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—Aminolevulinic acid—ALAD—kidney cancer	0.0159	1	CrCbGaD
Glycine—GLYAT—nephron tubule—kidney cancer	0.012	0.0363	CbGeAlD
Glycine—GLYATL1—renal system—kidney cancer	0.0116	0.0351	CbGeAlD
Glycine—GLYATL1—kidney—kidney cancer	0.0112	0.0339	CbGeAlD
Glycine—GLYAT—renal system—kidney cancer	0.0109	0.033	CbGeAlD
Glycine—GLYAT—kidney—kidney cancer	0.0106	0.0319	CbGeAlD
Glycine—GLYAT—cortex of kidney—kidney cancer	0.0103	0.0311	CbGeAlD
Glycine—AGXT—renal system—kidney cancer	0.00748	0.0226	CbGeAlD
Glycine—AGXT—kidney—kidney cancer	0.00723	0.0219	CbGeAlD
Glycine—GCSH—renal system—kidney cancer	0.00717	0.0217	CbGeAlD
Glycine—GCSH—kidney—kidney cancer	0.00693	0.021	CbGeAlD
Glycine—GPR18—gonad—kidney cancer	0.00686	0.0207	CbGeAlD
Glycine—GLDC—nephron tubule—kidney cancer	0.00654	0.0198	CbGeAlD
Glycine—AGXT2—renal system—kidney cancer	0.00636	0.0192	CbGeAlD
Glycine—Encephalopathy—Pazopanib—kidney cancer	0.00624	0.0295	CcSEcCtD
Glycine—AGXT2—kidney—kidney cancer	0.00615	0.0186	CbGeAlD
Glycine—PIPOX—nephron tubule—kidney cancer	0.0061	0.0185	CbGeAlD
Glycine—GLRA2—renal system—kidney cancer	0.0061	0.0184	CbGeAlD
Glycine—Lung disorder—Temsirolimus—kidney cancer	0.00601	0.0284	CcSEcCtD
Glycine—AGXT2—cortex of kidney—kidney cancer	0.00599	0.0181	CbGeAlD
Glycine—GLDC—renal system—kidney cancer	0.00594	0.018	CbGeAlD
Glycine—GLRA2—kidney—kidney cancer	0.00589	0.0178	CbGeAlD
Glycine—GLDC—kidney—kidney cancer	0.00574	0.0174	CbGeAlD
Glycine—Acidosis—Everolimus—kidney cancer	0.00572	0.027	CcSEcCtD
Glycine—AGXT2—gonad—kidney cancer	0.0057	0.0172	CbGeAlD
Glycine—GLDC—cortex of kidney—kidney cancer	0.00559	0.0169	CbGeAlD
Glycine—PIPOX—renal system—kidney cancer	0.00555	0.0168	CbGeAlD
Glycine—PIPOX—kidney—kidney cancer	0.00536	0.0162	CbGeAlD
Glycine—SHMT1—Vincristine—Vinblastine—kidney cancer	0.00529	0.554	CbGdCrCtD
Glycine—PIPOX—cortex of kidney—kidney cancer	0.00522	0.0158	CbGeAlD
Glycine—ALAS1—nephron tubule—kidney cancer	0.00519	0.0157	CbGeAlD
Glycine—GCAT—cortex of kidney—kidney cancer	0.00507	0.0153	CbGeAlD
Glycine—GARS—nephron tubule—kidney cancer	0.00473	0.0143	CbGeAlD
Glycine—ALAS1—renal system—kidney cancer	0.00472	0.0143	CbGeAlD
Glycine—ALAS1—kidney—kidney cancer	0.00456	0.0138	CbGeAlD
Glycine—GATM—nephron tubule—kidney cancer	0.00449	0.0136	CbGeAlD
Glycine—ALAS1—cortex of kidney—kidney cancer	0.00444	0.0134	CbGeAlD
Glycine—Lung disorder—Erlotinib—kidney cancer	0.00431	0.0204	CcSEcCtD
Glycine—GARS—renal system—kidney cancer	0.0043	0.013	CbGeAlD
Glycine—SHMT1—Vinblastine—Vincristine—kidney cancer	0.00425	0.446	CbGdCrCtD
Glycine—Electrolyte imbalance—Paclitaxel—kidney cancer	0.00425	0.0201	CcSEcCtD
Glycine—ALAS1—cardiac atrium—kidney cancer	0.00422	0.0128	CbGeAlD
Glycine—GARS—kidney—kidney cancer	0.00415	0.0126	CbGeAlD
Glycine—SHMT2—nephron tubule—kidney cancer	0.00411	0.0124	CbGeAlD
Glycine—GATM—renal system—kidney cancer	0.00408	0.0123	CbGeAlD
Glycine—GARS—cortex of kidney—kidney cancer	0.00404	0.0122	CbGeAlD
Glycine—GATM—kidney—kidney cancer	0.00394	0.0119	CbGeAlD
Glycine—GARS—gonad—kidney cancer	0.00385	0.0116	CbGeAlD
Glycine—GARS—cardiac atrium—kidney cancer	0.00385	0.0116	CbGeAlD
Glycine—GATM—cortex of kidney—kidney cancer	0.00384	0.0116	CbGeAlD
Glycine—SHMT1—nephron tubule—kidney cancer	0.00374	0.0113	CbGeAlD
Glycine—SHMT2—renal system—kidney cancer	0.00374	0.0113	CbGeAlD
Glycine—GATM—gonad—kidney cancer	0.00366	0.0111	CbGeAlD
Glycine—GATM—cardiac atrium—kidney cancer	0.00365	0.011	CbGeAlD
Glycine—SHMT2—kidney—kidney cancer	0.00361	0.0109	CbGeAlD
Glycine—Thrombophlebitis—Temsirolimus—kidney cancer	0.00357	0.0168	CcSEcCtD
Glycine—SHMT2—cortex of kidney—kidney cancer	0.00352	0.0106	CbGeAlD
Glycine—Cardiovascular disorder—Erlotinib—kidney cancer	0.00348	0.0164	CcSEcCtD
Glycine—SHMT1—renal system—kidney cancer	0.0034	0.0103	CbGeAlD
Glycine—SHMT2—gonad—kidney cancer	0.00335	0.0101	CbGeAlD
Glycine—SHMT1—kidney—kidney cancer	0.00329	0.00994	CbGeAlD
Glycine—SHMT1—cortex of kidney—kidney cancer	0.0032	0.00969	CbGeAlD
Glycine—SLC36A1—nephron tubule—kidney cancer	0.00319	0.00965	CbGeAlD
Glycine—SHMT1—gonad—kidney cancer	0.00305	0.00922	CbGeAlD
Glycine—Hyponatraemia—Pazopanib—kidney cancer	0.00292	0.0138	CcSEcCtD
Glycine—SLC36A1—renal system—kidney cancer	0.0029	0.00877	CbGeAlD
Glycine—Dehydration—Temsirolimus—kidney cancer	0.00287	0.0136	CcSEcCtD
Glycine—GSS—nephron tubule—kidney cancer	0.00281	0.0085	CbGeAlD
Glycine—SLC36A1—kidney—kidney cancer	0.00281	0.00848	CbGeAlD
Glycine—Encephalopathy—Paclitaxel—kidney cancer	0.00277	0.0131	CcSEcCtD
Glycine—SLC36A1—cortex of kidney—kidney cancer	0.00273	0.00826	CbGeAlD
Glycine—Dehydration—Pazopanib—kidney cancer	0.00271	0.0128	CcSEcCtD
Glycine—Polyuria—Everolimus—kidney cancer	0.00262	0.0123	CcSEcCtD
Glycine—SLC36A1—gonad—kidney cancer	0.0026	0.00787	CbGeAlD
Glycine—GSS—renal system—kidney cancer	0.00255	0.00772	CbGeAlD
Glycine—GSS—kidney—kidney cancer	0.00247	0.00747	CbGeAlD
Glycine—GSS—cortex of kidney—kidney cancer	0.00241	0.00727	CbGeAlD
Glycine—Hyponatraemia—Everolimus—kidney cancer	0.00231	0.0109	CcSEcCtD
Glycine—GSS—gonad—kidney cancer	0.00229	0.00693	CbGeAlD
Glycine—GSS—cardiac atrium—kidney cancer	0.00229	0.00692	CbGeAlD
Glycine—Encephalopathy—Capecitabine—kidney cancer	0.00227	0.0107	CcSEcCtD
Glycine—Urinary retention—Everolimus—kidney cancer	0.00218	0.0103	CcSEcCtD
Glycine—Rhinitis—Temsirolimus—kidney cancer	0.00214	0.0101	CcSEcCtD
Glycine—Dehydration—Everolimus—kidney cancer	0.00214	0.0101	CcSEcCtD
Glycine—Dehydration—Erlotinib—kidney cancer	0.00206	0.00973	CcSEcCtD
Glycine—SLC16A10—nephron tubule—kidney cancer	0.00206	0.00622	CbGeAlD
Glycine—Coma—Vincristine—kidney cancer	0.00204	0.00964	CcSEcCtD
Glycine—Hyponatraemia—Sorafenib—kidney cancer	0.002	0.00945	CcSEcCtD
Glycine—Angina pectoris—Vinblastine—kidney cancer	0.00194	0.00916	CcSEcCtD
Glycine—Angina pectoris—Everolimus—kidney cancer	0.00193	0.00913	CcSEcCtD
Glycine—Hyponatraemia—Sunitinib—kidney cancer	0.00193	0.00909	CcSEcCtD
Glycine—Chills—Temsirolimus—kidney cancer	0.00192	0.00905	CcSEcCtD
Glycine—Dehydration—Sorafenib—kidney cancer	0.00185	0.00875	CcSEcCtD
Glycine—Polyuria—Vincristine—kidney cancer	0.00185	0.00872	CcSEcCtD
Glycine—Chills—Pazopanib—kidney cancer	0.00181	0.00852	CcSEcCtD
Glycine—Back pain—Temsirolimus—kidney cancer	0.0018	0.00849	CcSEcCtD
Glycine—Dehydration—Sunitinib—kidney cancer	0.00178	0.00842	CcSEcCtD
Glycine—SLC16A10—cortex of kidney—kidney cancer	0.00176	0.00533	CbGeAlD
Glycine—SLC16A10—gonad—kidney cancer	0.00168	0.00507	CbGeAlD
Glycine—Vision blurred—Pazopanib—kidney cancer	0.00165	0.00779	CcSEcCtD
Glycine—Hyponatraemia—Vincristine—kidney cancer	0.00163	0.00769	CcSEcCtD
Glycine—Convulsion—Temsirolimus—kidney cancer	0.00161	0.00761	CcSEcCtD
Glycine—Rhinitis—Everolimus—kidney cancer	0.00159	0.00752	CcSEcCtD
Glycine—Lightheadedness—Paclitaxel—kidney cancer	0.00159	0.0075	CcSEcCtD
Glycine—Urinary retention—Vincristine—kidney cancer	0.00154	0.00728	CcSEcCtD
Glycine—Oedema—Temsirolimus—kidney cancer	0.00152	0.00716	CcSEcCtD
Glycine—Dehydration—Vincristine—kidney cancer	0.00151	0.00712	CcSEcCtD
Glycine—Thrombophlebitis—Paclitaxel—kidney cancer	0.00149	0.00703	CcSEcCtD
Glycine—Polyuria—Paclitaxel—kidney cancer	0.00147	0.00693	CcSEcCtD
Glycine—Oedema—Pazopanib—kidney cancer	0.00143	0.00675	CcSEcCtD
Glycine—Chills—Everolimus—kidney cancer	0.00143	0.00673	CcSEcCtD
Glycine—Chills—Erlotinib—kidney cancer	0.00138	0.00649	CcSEcCtD
Glycine—Visual disturbance—Paclitaxel—kidney cancer	0.00136	0.00642	CcSEcCtD
Glycine—Back pain—Everolimus—kidney cancer	0.00134	0.00632	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—kidney cancer	0.00133	0.00626	CcSEcCtD
Glycine—Vision blurred—Everolimus—kidney cancer	0.0013	0.00615	CcSEcCtD
Glycine—Pain—Temsirolimus—kidney cancer	0.0013	0.00613	CcSEcCtD
Glycine—Hyponatraemia—Paclitaxel—kidney cancer	0.00129	0.00611	CcSEcCtD
Glycine—Back pain—Erlotinib—kidney cancer	0.00129	0.00609	CcSEcCtD
Glycine—Vertigo—Vinblastine—kidney cancer	0.00125	0.00589	CcSEcCtD
Glycine—Pain—Pazopanib—kidney cancer	0.00122	0.00577	CcSEcCtD
Glycine—Thrombophlebitis—Capecitabine—kidney cancer	0.00122	0.00577	CcSEcCtD
Glycine—Polyuria—Capecitabine—kidney cancer	0.0012	0.00569	CcSEcCtD
Glycine—Convulsion—Vinblastine—kidney cancer	0.0012	0.00568	CcSEcCtD
Glycine—Dehydration—Paclitaxel—kidney cancer	0.0012	0.00566	CcSEcCtD
Glycine—Convulsion—Everolimus—kidney cancer	0.0012	0.00566	CcSEcCtD
Glycine—Chills—Sunitinib—kidney cancer	0.00119	0.00562	CcSEcCtD
Glycine—Oedema—Everolimus—kidney cancer	0.00113	0.00533	CcSEcCtD
Glycine—Chills—Dactinomycin—kidney cancer	0.00113	0.00532	CcSEcCtD
Glycine—Hypersensitivity—Temsirolimus—kidney cancer	0.00112	0.00528	CcSEcCtD
Glycine—Back pain—Sunitinib—kidney cancer	0.00112	0.00528	CcSEcCtD
Glycine—Thirst—Capecitabine—kidney cancer	0.00111	0.00525	CcSEcCtD
Glycine—Tachycardia—Everolimus—kidney cancer	0.0011	0.0052	CcSEcCtD
Glycine—Oedema—Erlotinib—kidney cancer	0.00109	0.00514	CcSEcCtD
Glycine—Cardiovascular disorder—Doxorubicin—kidney cancer	0.00107	0.00505	CcSEcCtD
Glycine—Rhinitis—Gemcitabine—kidney cancer	0.00107	0.00504	CcSEcCtD
Glycine—Hyponatraemia—Capecitabine—kidney cancer	0.00106	0.00501	CcSEcCtD
Glycine—Hypotension—Everolimus—kidney cancer	0.00106	0.00498	CcSEcCtD
Glycine—Diarrhoea—Temsirolimus—kidney cancer	0.00104	0.0049	CcSEcCtD
Glycine—Urinary retention—Capecitabine—kidney cancer	0.00101	0.00475	CcSEcCtD
Glycine—Dizziness—Temsirolimus—kidney cancer	0.001	0.00474	CcSEcCtD
Glycine—Convulsion—Sunitinib—kidney cancer	0.001	0.00473	CcSEcCtD
Glycine—Dehydration—Capecitabine—kidney cancer	0.000984	0.00464	CcSEcCtD
Glycine—Diarrhoea—Pazopanib—kidney cancer	0.000979	0.00462	CcSEcCtD
Glycine—Pain—Vinblastine—kidney cancer	0.000969	0.00457	CcSEcCtD
Glycine—Pain—Everolimus—kidney cancer	0.000966	0.00456	CcSEcCtD
Glycine—Vomiting—Temsirolimus—kidney cancer	0.000965	0.00455	CcSEcCtD
Glycine—Chills—Gemcitabine—kidney cancer	0.000956	0.00451	CcSEcCtD
Glycine—Dizziness—Pazopanib—kidney cancer	0.000946	0.00446	CcSEcCtD
Glycine—Back pain—Vincristine—kidney cancer	0.000945	0.00446	CcSEcCtD
Glycine—Oedema—Sunitinib—kidney cancer	0.000943	0.00445	CcSEcCtD
Glycine—Pain—Erlotinib—kidney cancer	0.000932	0.0044	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000912	0.00431	CcSEcCtD
Glycine—Vomiting—Pazopanib—kidney cancer	0.000909	0.00429	CcSEcCtD
Glycine—Nausea—Temsirolimus—kidney cancer	0.000902	0.00426	CcSEcCtD
Glycine—Back pain—Gemcitabine—kidney cancer	0.000897	0.00423	CcSEcCtD
Glycine—Rhinitis—Paclitaxel—kidney cancer	0.000894	0.00422	CcSEcCtD
Glycine—Oedema—Dactinomycin—kidney cancer	0.000893	0.00421	CcSEcCtD
Glycine—Angina pectoris—Capecitabine—kidney cancer	0.000891	0.0042	CcSEcCtD
Glycine—Vertigo—Vincristine—kidney cancer	0.000878	0.00414	CcSEcCtD
Glycine—Visual impairment—Paclitaxel—kidney cancer	0.000859	0.00406	CcSEcCtD
Glycine—Coma—Doxorubicin—kidney cancer	0.000858	0.00405	CcSEcCtD
Glycine—Nausea—Pazopanib—kidney cancer	0.000849	0.00401	CcSEcCtD
Glycine—Convulsion—Vincristine—kidney cancer	0.000847	0.004	CcSEcCtD
Glycine—Pain—Sorafenib—kidney cancer	0.000838	0.00396	CcSEcCtD
Glycine—Hypersensitivity—Vinblastine—kidney cancer	0.000835	0.00394	CcSEcCtD
Glycine—Hypersensitivity—Everolimus—kidney cancer	0.000832	0.00393	CcSEcCtD
Glycine—Pain—Sunitinib—kidney cancer	0.000807	0.00381	CcSEcCtD
Glycine—Chills—Paclitaxel—kidney cancer	0.0008	0.00378	CcSEcCtD
Glycine—Oedema—Vincristine—kidney cancer	0.000798	0.00376	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—kidney cancer	0.000788	0.00372	CcSEcCtD
Glycine—Urticaria—Sorafenib—kidney cancer	0.000779	0.00367	CcSEcCtD
Glycine—Diarrhoea—Vinblastine—kidney cancer	0.000776	0.00366	CcSEcCtD
Glycine—Diarrhoea—Everolimus—kidney cancer	0.000773	0.00365	CcSEcCtD
Glycine—Pain—Dactinomycin—kidney cancer	0.000764	0.0036	CcSEcCtD
Glycine—Oedema—Gemcitabine—kidney cancer	0.000757	0.00357	CcSEcCtD
Glycine—Back pain—Paclitaxel—kidney cancer	0.000751	0.00354	CcSEcCtD
Glycine—Dizziness—Vinblastine—kidney cancer	0.00075	0.00354	CcSEcCtD
Glycine—Dizziness—Everolimus—kidney cancer	0.000747	0.00352	CcSEcCtD
Glycine—Diarrhoea—Erlotinib—kidney cancer	0.000745	0.00352	CcSEcCtD
Glycine—Hypotension—Vincristine—kidney cancer	0.000745	0.00352	CcSEcCtD
Glycine—Rhinitis—Capecitabine—kidney cancer	0.000734	0.00346	CcSEcCtD
Glycine—Vision blurred—Paclitaxel—kidney cancer	0.000732	0.00345	CcSEcCtD
Glycine—Hypersensitivity—Sorafenib—kidney cancer	0.000722	0.00341	CcSEcCtD
Glycine—Vomiting—Vinblastine—kidney cancer	0.000721	0.0034	CcSEcCtD
Glycine—Dizziness—Erlotinib—kidney cancer	0.00072	0.0034	CcSEcCtD
Glycine—Vomiting—Everolimus—kidney cancer	0.000718	0.00339	CcSEcCtD
Glycine—Hypotension—Gemcitabine—kidney cancer	0.000707	0.00334	CcSEcCtD
Glycine—Visual impairment—Capecitabine—kidney cancer	0.000705	0.00333	CcSEcCtD
Glycine—Vertigo—Paclitaxel—kidney cancer	0.000698	0.00329	CcSEcCtD
Glycine—Hypersensitivity—Sunitinib—kidney cancer	0.000695	0.00328	CcSEcCtD
Glycine—Vomiting—Erlotinib—kidney cancer	0.000693	0.00327	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—kidney cancer	0.000685	0.00323	CcSEcCtD
Glycine—Pain—Vincristine—kidney cancer	0.000682	0.00322	CcSEcCtD
Glycine—Nausea—Vinblastine—kidney cancer	0.000673	0.00318	CcSEcCtD
Glycine—Convulsion—Paclitaxel—kidney cancer	0.000673	0.00317	CcSEcCtD
Glycine—Nausea—Everolimus—kidney cancer	0.000671	0.00317	CcSEcCtD
Glycine—Diarrhoea—Sorafenib—kidney cancer	0.000671	0.00316	CcSEcCtD
Glycine—Hypersensitivity—Dactinomycin—kidney cancer	0.000658	0.0031	CcSEcCtD
Glycine—Chills—Capecitabine—kidney cancer	0.000657	0.0031	CcSEcCtD
Glycine—Dizziness—Sorafenib—kidney cancer	0.000648	0.00306	CcSEcCtD
Glycine—Pain—Gemcitabine—kidney cancer	0.000647	0.00305	CcSEcCtD
Glycine—Nausea—Erlotinib—kidney cancer	0.000647	0.00305	CcSEcCtD
Glycine—Diarrhoea—Sunitinib—kidney cancer	0.000645	0.00305	CcSEcCtD
Glycine—Dehydration—Doxorubicin—kidney cancer	0.000634	0.00299	CcSEcCtD
Glycine—Oedema—Paclitaxel—kidney cancer	0.000634	0.00299	CcSEcCtD
Glycine—Dizziness—Sunitinib—kidney cancer	0.000624	0.00294	CcSEcCtD
Glycine—Vomiting—Sorafenib—kidney cancer	0.000623	0.00294	CcSEcCtD
Glycine—Tachycardia—Paclitaxel—kidney cancer	0.000618	0.00292	CcSEcCtD
Glycine—Back pain—Capecitabine—kidney cancer	0.000616	0.00291	CcSEcCtD
Glycine—Diarrhoea—Dactinomycin—kidney cancer	0.000611	0.00288	CcSEcCtD
Glycine—Vision blurred—Capecitabine—kidney cancer	0.0006	0.00283	CcSEcCtD
Glycine—Vomiting—Sunitinib—kidney cancer	0.0006	0.00283	CcSEcCtD
Glycine—Hypotension—Paclitaxel—kidney cancer	0.000592	0.00279	CcSEcCtD
Glycine—Hypersensitivity—Vincristine—kidney cancer	0.000588	0.00277	CcSEcCtD
Glycine—Nausea—Sorafenib—kidney cancer	0.000582	0.00275	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—kidney cancer	0.000574	0.00271	CcSEcCtD
Glycine—Vertigo—Capecitabine—kidney cancer	0.000572	0.0027	CcSEcCtD
Glycine—Vomiting—Dactinomycin—kidney cancer	0.000568	0.00268	CcSEcCtD
Glycine—Nausea—Sunitinib—kidney cancer	0.00056	0.00264	CcSEcCtD
Glycine—Diarrhoea—Vincristine—kidney cancer	0.000546	0.00258	CcSEcCtD
Glycine—Pain—Paclitaxel—kidney cancer	0.000542	0.00256	CcSEcCtD
Glycine—Nausea—Dactinomycin—kidney cancer	0.00053	0.0025	CcSEcCtD
Glycine—Dizziness—Vincristine—kidney cancer	0.000528	0.00249	CcSEcCtD
Glycine—Oedema—Capecitabine—kidney cancer	0.00052	0.00245	CcSEcCtD
Glycine—Diarrhoea—Gemcitabine—kidney cancer	0.000518	0.00244	CcSEcCtD
Glycine—Tachycardia—Capecitabine—kidney cancer	0.000507	0.00239	CcSEcCtD
Glycine—Vomiting—Vincristine—kidney cancer	0.000507	0.00239	CcSEcCtD
Glycine—Urticaria—Paclitaxel—kidney cancer	0.000503	0.00238	CcSEcCtD
Glycine—Hypotension—Capecitabine—kidney cancer	0.000486	0.00229	CcSEcCtD
Glycine—Vomiting—Gemcitabine—kidney cancer	0.000481	0.00227	CcSEcCtD
Glycine—Nausea—Vincristine—kidney cancer	0.000474	0.00224	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—kidney cancer	0.000473	0.00223	CcSEcCtD
Glycine—Hypersensitivity—Paclitaxel—kidney cancer	0.000467	0.0022	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—kidney cancer	0.000455	0.00215	CcSEcCtD
Glycine—Nausea—Gemcitabine—kidney cancer	0.00045	0.00212	CcSEcCtD
Glycine—Pain—Capecitabine—kidney cancer	0.000445	0.0021	CcSEcCtD
Glycine—Diarrhoea—Paclitaxel—kidney cancer	0.000434	0.00205	CcSEcCtD
Glycine—Chills—Doxorubicin—kidney cancer	0.000423	0.002	CcSEcCtD
Glycine—Dizziness—Paclitaxel—kidney cancer	0.000419	0.00198	CcSEcCtD
Glycine—Urticaria—Capecitabine—kidney cancer	0.000413	0.00195	CcSEcCtD
Glycine—Vomiting—Paclitaxel—kidney cancer	0.000403	0.0019	CcSEcCtD
Glycine—Back pain—Doxorubicin—kidney cancer	0.000397	0.00187	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—kidney cancer	0.000387	0.00183	CcSEcCtD
Glycine—Hypersensitivity—Capecitabine—kidney cancer	0.000383	0.00181	CcSEcCtD
Glycine—Nausea—Paclitaxel—kidney cancer	0.000376	0.00178	CcSEcCtD
Glycine—Vertigo—Doxorubicin—kidney cancer	0.000369	0.00174	CcSEcCtD
Glycine—Convulsion—Doxorubicin—kidney cancer	0.000356	0.00168	CcSEcCtD
Glycine—Diarrhoea—Capecitabine—kidney cancer	0.000356	0.00168	CcSEcCtD
Glycine—Dizziness—Capecitabine—kidney cancer	0.000344	0.00162	CcSEcCtD
Glycine—Oedema—Doxorubicin—kidney cancer	0.000335	0.00158	CcSEcCtD
Glycine—Vomiting—Capecitabine—kidney cancer	0.000331	0.00156	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—kidney cancer	0.000327	0.00154	CcSEcCtD
Glycine—Hypotension—Doxorubicin—kidney cancer	0.000313	0.00148	CcSEcCtD
Glycine—Nausea—Capecitabine—kidney cancer	0.000309	0.00146	CcSEcCtD
Glycine—Pain—Doxorubicin—kidney cancer	0.000287	0.00135	CcSEcCtD
Glycine—Urticaria—Doxorubicin—kidney cancer	0.000266	0.00126	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—kidney cancer	0.000247	0.00117	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—kidney cancer	0.000229	0.00108	CcSEcCtD
Glycine—Dizziness—Doxorubicin—kidney cancer	0.000222	0.00105	CcSEcCtD
Glycine—Vomiting—Doxorubicin—kidney cancer	0.000213	0.00101	CcSEcCtD
Glycine—Nausea—Doxorubicin—kidney cancer	0.000199	0.00094	CcSEcCtD
Glycine—ALAS2—Metabolism—ABCB1—kidney cancer	0.000131	0.000304	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000131	0.000303	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—SLC5A5—kidney cancer	0.000131	0.000303	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—SLC5A5—kidney cancer	0.000131	0.000303	CbGpPWpGaD
Glycine—GATM—Metabolism—SLC5A5—kidney cancer	0.000131	0.000303	CbGpPWpGaD
Glycine—GLYAT—Metabolism—SLC5A5—kidney cancer	0.000131	0.000303	CbGpPWpGaD
Glycine—SHMT1—Disease—RPL14—kidney cancer	0.00013	0.0003	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CRABP1—kidney cancer	0.00013	0.0003	CbGpPWpGaD
Glycine—AGXT—Metabolism—GSTT1—kidney cancer	0.000129	0.000299	CbGpPWpGaD
Glycine—AGXT—Metabolism—ACHE—kidney cancer	0.000129	0.000299	CbGpPWpGaD
Glycine—ALAS2—Metabolism—GSTM1—kidney cancer	0.000128	0.000295	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000126	0.000293	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNA1—kidney cancer	0.000126	0.000292	CbGpPWpGaD
Glycine—GLYAT—Metabolism—SLC2A1—kidney cancer	0.000126	0.000292	CbGpPWpGaD
Glycine—GATM—Metabolism—SLC2A1—kidney cancer	0.000126	0.000292	CbGpPWpGaD
Glycine—BAAT—Metabolism—BCHE—kidney cancer	0.000126	0.000292	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—SLC2A1—kidney cancer	0.000126	0.000292	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—SLC2A1—kidney cancer	0.000126	0.000292	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HSPB1—kidney cancer	0.000126	0.000291	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EIF4EBP1—kidney cancer	0.000126	0.000291	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTT1—kidney cancer	0.000125	0.00029	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ACHE—kidney cancer	0.000125	0.00029	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—kidney cancer	0.000125	0.000289	CbGpPWpGaD
Glycine—BAAT—Metabolism—SLC5A5—kidney cancer	0.000125	0.000289	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CA9—kidney cancer	0.000124	0.000287	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—BRAF—kidney cancer	0.000124	0.000287	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000124	0.000286	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000123	0.000285	CbGpPWpGaD
Glycine—AGXT—Metabolism—SCARB1—kidney cancer	0.000122	0.000283	CbGpPWpGaD
Glycine—GSS—Metabolism—CA9—kidney cancer	0.000121	0.00028	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CYP1A1—kidney cancer	0.000121	0.00028	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS1—kidney cancer	0.000121	0.00028	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ITPR2—kidney cancer	0.00012	0.000279	CbGpPWpGaD
Glycine—BAAT—Metabolism—SLC2A1—kidney cancer	0.00012	0.000279	CbGpPWpGaD
Glycine—AGXT—Metabolism—PSMD7—kidney cancer	0.000119	0.000275	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SCARB1—kidney cancer	0.000118	0.000274	CbGpPWpGaD
Glycine—SHMT1—Disease—ITPR2—kidney cancer	0.000117	0.000271	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS1—kidney cancer	0.000117	0.000271	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000117	0.00027	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TSC1—kidney cancer	0.000117	0.00027	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PSMD7—kidney cancer	0.000117	0.00027	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ANXA1—kidney cancer	0.000117	0.00027	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000117	0.00027	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PSMD7—kidney cancer	0.000115	0.000266	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000115	0.000266	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000115	0.000266	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000115	0.000266	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FLT1—kidney cancer	0.000113	0.000262	CbGpPWpGaD
Glycine—AGXT—Metabolism—BCHE—kidney cancer	0.000112	0.00026	CbGpPWpGaD
Glycine—AGXT—Metabolism—SLC5A5—kidney cancer	0.000111	0.000257	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ACHE—kidney cancer	0.00011	0.000254	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTT1—kidney cancer	0.00011	0.000254	CbGpPWpGaD
Glycine—ALAS1—Metabolism—BCHE—kidney cancer	0.000109	0.000252	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SLC5A5—kidney cancer	0.000108	0.000249	CbGpPWpGaD
Glycine—AGXT—Metabolism—SLC2A1—kidney cancer	0.000107	0.000248	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—POMC—kidney cancer	0.000107	0.000247	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CRABP1—kidney cancer	0.000106	0.000244	CbGpPWpGaD
Glycine—GATM—Metabolism—GSTP1—kidney cancer	0.000105	0.000244	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GSTP1—kidney cancer	0.000105	0.000244	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GSTP1—kidney cancer	0.000105	0.000244	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GSTP1—kidney cancer	0.000105	0.000244	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PAK1—kidney cancer	0.000105	0.000243	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUNB—kidney cancer	0.000105	0.000243	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SLC2A1—kidney cancer	0.000104	0.000241	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SCARB1—kidney cancer	0.000104	0.000241	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—RAF1—kidney cancer	0.000104	0.00024	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000103	0.000239	CbGpPWpGaD
Glycine—GSS—Metabolism—CRABP1—kidney cancer	0.000103	0.000238	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS1—kidney cancer	0.000103	0.000238	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000102	0.000236	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PSMD7—kidney cancer	0.000101	0.000234	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000101	0.000233	CbGpPWpGaD
Glycine—BAAT—Metabolism—GSTP1—kidney cancer	0.0001	0.000232	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ABCB1—kidney cancer	9.96e-05	0.000231	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ABCB1—kidney cancer	9.96e-05	0.000231	CbGpPWpGaD
Glycine—GATM—Metabolism—ABCB1—kidney cancer	9.96e-05	0.000231	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ABCB1—kidney cancer	9.96e-05	0.000231	CbGpPWpGaD
Glycine—SHMT1—Disease—PSMD7—kidney cancer	9.82e-05	0.000227	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ITPR2—kidney cancer	9.81e-05	0.000227	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—POMC—kidney cancer	9.68e-05	0.000224	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GSTM1—kidney cancer	9.67e-05	0.000224	CbGpPWpGaD
Glycine—GATM—Metabolism—GSTM1—kidney cancer	9.67e-05	0.000224	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GSTM1—kidney cancer	9.67e-05	0.000224	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GSTM1—kidney cancer	9.67e-05	0.000224	CbGpPWpGaD
Glycine—GSS—Metabolism—ITPR2—kidney cancer	9.56e-05	0.000221	CbGpPWpGaD
Glycine—AGXT2—Metabolism—BCHE—kidney cancer	9.56e-05	0.000221	CbGpPWpGaD
Glycine—BAAT—Metabolism—ABCB1—kidney cancer	9.51e-05	0.00022	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—BRAF—kidney cancer	9.47e-05	0.000219	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SLC5A5—kidney cancer	9.45e-05	0.000219	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	9.41e-05	0.000218	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—RAF1—kidney cancer	9.36e-05	0.000217	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.29e-05	0.000215	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.27e-05	0.000215	CbGpPWpGaD
Glycine—BAAT—Metabolism—GSTM1—kidney cancer	9.23e-05	0.000214	CbGpPWpGaD
Glycine—GATM—Metabolism—CYP1A1—kidney cancer	9.17e-05	0.000212	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CYP1A1—kidney cancer	9.17e-05	0.000212	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CYP1A1—kidney cancer	9.17e-05	0.000212	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CYP1A1—kidney cancer	9.17e-05	0.000212	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SLC2A1—kidney cancer	9.12e-05	0.000211	CbGpPWpGaD
Glycine—ALAS2—Metabolism—POMC—kidney cancer	9.02e-05	0.000209	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.97e-05	0.000208	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTT1—kidney cancer	8.95e-05	0.000207	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ACHE—kidney cancer	8.95e-05	0.000207	CbGpPWpGaD
Glycine—AGXT—Metabolism—GSTP1—kidney cancer	8.95e-05	0.000207	CbGpPWpGaD
Glycine—SHMT1—Disease—SLC2A1—kidney cancer	8.88e-05	0.000206	CbGpPWpGaD
Glycine—SHMT1—Disease—JUNB—kidney cancer	8.82e-05	0.000204	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.79e-05	0.000204	CbGpPWpGaD
Glycine—BAAT—Metabolism—CYP1A1—kidney cancer	8.75e-05	0.000203	CbGpPWpGaD
Glycine—GSS—Metabolism—ACHE—kidney cancer	8.72e-05	0.000202	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTT1—kidney cancer	8.72e-05	0.000202	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTP1—kidney cancer	8.67e-05	0.000201	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF2—kidney cancer	8.56e-05	0.000198	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN2B—kidney cancer	8.53e-05	0.000197	CbGpPWpGaD
Glycine—AGXT—Metabolism—ABCB1—kidney cancer	8.47e-05	0.000196	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SCARB1—kidney cancer	8.47e-05	0.000196	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS1—kidney cancer	8.39e-05	0.000194	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1R—kidney cancer	8.28e-05	0.000192	CbGpPWpGaD
Glycine—GSS—Metabolism—SCARB1—kidney cancer	8.26e-05	0.000191	CbGpPWpGaD
Glycine—AGXT—Metabolism—GSTM1—kidney cancer	8.22e-05	0.00019	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PSMD7—kidney cancer	8.22e-05	0.00019	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ABCB1—kidney cancer	8.21e-05	0.00019	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS1—kidney cancer	8.17e-05	0.000189	CbGpPWpGaD
Glycine—GSS—Metabolism—PSMD7—kidney cancer	8.02e-05	0.000186	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—RAF1—kidney cancer	7.98e-05	0.000185	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTM1—kidney cancer	7.97e-05	0.000184	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—RAF1—kidney cancer	7.9e-05	0.000183	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—kidney cancer	7.88e-05	0.000182	CbGpPWpGaD
Glycine—SHMT1—Metabolism—BCHE—kidney cancer	7.8e-05	0.000181	CbGpPWpGaD
Glycine—AGXT—Metabolism—CYP1A1—kidney cancer	7.8e-05	0.000181	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC5A5—kidney cancer	7.7e-05	0.000178	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTP1—kidney cancer	7.61e-05	0.000176	CbGpPWpGaD
Glycine—GSS—Metabolism—BCHE—kidney cancer	7.6e-05	0.000176	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP1A1—kidney cancer	7.55e-05	0.000175	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC5A5—kidney cancer	7.51e-05	0.000174	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC2A1—kidney cancer	7.44e-05	0.000172	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	7.4e-05	0.000171	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC2A1—kidney cancer	7.25e-05	0.000168	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—kidney cancer	7.2e-05	0.000167	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—kidney cancer	7.2e-05	0.000167	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.19e-05	0.000166	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN2B—kidney cancer	7.18e-05	0.000166	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—kidney cancer	7.15e-05	0.000166	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MAPK1—kidney cancer	7.1e-05	0.000164	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.08e-05	0.000164	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.08e-05	0.000164	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—kidney cancer	6.99e-05	0.000162	CbGpPWpGaD
Glycine—GARS—Gene Expression—MAPK3—kidney cancer	6.9e-05	0.00016	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—POMC—kidney cancer	6.84e-05	0.000158	CbGpPWpGaD
Glycine—GATM—Metabolism—POMC—kidney cancer	6.84e-05	0.000158	CbGpPWpGaD
Glycine—GLYAT—Metabolism—POMC—kidney cancer	6.84e-05	0.000158	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—POMC—kidney cancer	6.84e-05	0.000158	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HIF1A—kidney cancer	6.82e-05	0.000158	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TSC2—kidney cancer	6.8e-05	0.000157	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—kidney cancer	6.71e-05	0.000155	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP1A1—kidney cancer	6.63e-05	0.000153	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.59e-05	0.000153	CbGpPWpGaD
Glycine—BAAT—Metabolism—POMC—kidney cancer	6.52e-05	0.000151	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—kidney cancer	6.52e-05	0.000151	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—kidney cancer	6.28e-05	0.000145	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTP1—kidney cancer	6.2e-05	0.000144	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.2e-05	0.000144	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTP1—kidney cancer	6.05e-05	0.00014	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APC—kidney cancer	6.01e-05	0.000139	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KIT—kidney cancer	6.01e-05	0.000139	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—kidney cancer	5.87e-05	0.000136	CbGpPWpGaD
Glycine—AGXT—Metabolism—POMC—kidney cancer	5.81e-05	0.000135	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK3—kidney cancer	5.75e-05	0.000133	CbGpPWpGaD
Glycine—SHMT1—Disease—HIF1A—kidney cancer	5.74e-05	0.000133	CbGpPWpGaD
Glycine—SHMT1—Disease—TSC2—kidney cancer	5.72e-05	0.000132	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—kidney cancer	5.72e-05	0.000132	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—POMC—kidney cancer	5.72e-05	0.000132	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—kidney cancer	5.7e-05	0.000132	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BRAF—kidney cancer	5.65e-05	0.000131	CbGpPWpGaD
Glycine—ALAS1—Metabolism—POMC—kidney cancer	5.63e-05	0.00013	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—kidney cancer	5.56e-05	0.000129	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—MAPK1—kidney cancer	5.47e-05	0.000127	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—kidney cancer	5.45e-05	0.000126	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—kidney cancer	5.45e-05	0.000126	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—kidney cancer	5.45e-05	0.000126	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—kidney cancer	5.45e-05	0.000126	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MAPK1—kidney cancer	5.42e-05	0.000126	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP1A1—kidney cancer	5.4e-05	0.000125	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP1A1—kidney cancer	5.27e-05	0.000122	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—kidney cancer	5.23e-05	0.000121	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—kidney cancer	5.2e-05	0.00012	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—kidney cancer	5.17e-05	0.00012	CbGpPWpGaD
Glycine—SHMT1—Disease—KIT—kidney cancer	5.05e-05	0.000117	CbGpPWpGaD
Glycine—SHMT1—Disease—APC—kidney cancer	5.05e-05	0.000117	CbGpPWpGaD
Glycine—AGXT2—Metabolism—POMC—kidney cancer	4.94e-05	0.000114	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—kidney cancer	4.76e-05	0.00011	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—kidney cancer	4.76e-05	0.00011	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—kidney cancer	4.76e-05	0.00011	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—kidney cancer	4.76e-05	0.00011	CbGpPWpGaD
Glycine—SHMT1—Disease—BRAF—kidney cancer	4.75e-05	0.00011	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—kidney cancer	4.75e-05	0.00011	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RAF1—kidney cancer	4.71e-05	0.000109	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RELA—kidney cancer	4.69e-05	0.000109	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—kidney cancer	4.66e-05	0.000108	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—kidney cancer	4.64e-05	0.000107	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—kidney cancer	4.6e-05	0.000107	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—kidney cancer	4.54e-05	0.000105	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—kidney cancer	4.49e-05	0.000104	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—kidney cancer	4.43e-05	0.000102	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1B—kidney cancer	4.32e-05	0.0001	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—kidney cancer	4.23e-05	9.78e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—kidney cancer	4.12e-05	9.54e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUN—kidney cancer	4.11e-05	9.52e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CTNNB1—kidney cancer	4.08e-05	9.45e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—kidney cancer	4.04e-05	9.36e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—POMC—kidney cancer	4.03e-05	9.33e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—RAF1—kidney cancer	4.01e-05	9.28e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—kidney cancer	3.98e-05	9.21e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—RAF1—kidney cancer	3.97e-05	9.18e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—kidney cancer	3.94e-05	9.13e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—POMC—kidney cancer	3.93e-05	9.09e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—kidney cancer	3.92e-05	9.09e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—kidney cancer	3.92e-05	9.07e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—kidney cancer	3.87e-05	8.97e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—kidney cancer	3.87e-05	8.95e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—kidney cancer	3.84e-05	8.88e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1B—kidney cancer	3.63e-05	8.41e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—kidney cancer	3.59e-05	8.32e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—kidney cancer	3.44e-05	7.96e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CTNNB1—kidney cancer	3.43e-05	7.95e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK3—kidney cancer	3.4e-05	7.87e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—kidney cancer	3.36e-05	7.77e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—kidney cancer	3.36e-05	7.77e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—kidney cancer	3.36e-05	7.77e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—kidney cancer	3.36e-05	7.77e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—kidney cancer	3.35e-05	7.75e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—kidney cancer	3.3e-05	7.65e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK1—kidney cancer	3.23e-05	7.48e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—kidney cancer	3.21e-05	7.44e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—kidney cancer	3.2e-05	7.41e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—kidney cancer	3.13e-05	7.25e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—kidney cancer	3.05e-05	7.07e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK3—kidney cancer	2.86e-05	6.62e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—kidney cancer	2.85e-05	6.6e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—kidney cancer	2.81e-05	6.49e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—kidney cancer	2.8e-05	6.49e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—kidney cancer	2.78e-05	6.44e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—kidney cancer	2.76e-05	6.4e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—kidney cancer	2.73e-05	6.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MAPK1—kidney cancer	2.72e-05	6.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—kidney cancer	2.71e-05	6.28e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—kidney cancer	2.57e-05	5.95e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—kidney cancer	2.43e-05	5.62e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—kidney cancer	2.36e-05	5.47e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—kidney cancer	1.98e-05	4.58e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—kidney cancer	1.93e-05	4.46e-05	CbGpPWpGaD
